Occudo Quantitative Strategies LP Atai Life Sciences N.V. Transaction History

Occudo Quantitative Strategies LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$2.38 - $3.55 $230,981 - $344,531	-97,051 Reduced 89.48%	11,415 $30,000
Q3 2022 Nov 14, 2022	BUY	$3.14 - $4.87 $8,600 - $13,338	2,739 Added 2.59%	108,466 $359,000
Q2 2022 Aug 15, 2022	BUY	$3.03 - $5.32 $185,423 - $325,562	61,196 Added 137.42%	105,727 $385,000
Q1 2022 May 16, 2022	BUY	$4.66 - $7.66 $133,555 - $219,535	28,660 Added 180.58%	44,531 $227,000
Q4 2021 Feb 14, 2022	BUY	$6.82 - $17.8 $108,240 - $282,503	15,871 New	15,871 $121,000

12.8M

9.2K

118K

Ticker ATAI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 165,875,008
Market Cap $189M
Description
Atai Life Sciences N.V., through its subsidiary, ATAI Life Sciences AG, operates as a clinical-stage biopharmaceutical company. It engages in developing various therapeutic candidates that focuses on various mental health disorders. The company's therapeutic candidates include PCN-101, a subcutaneous formulation of R-ketamine for the treatment o...

Get notified when there are updates to the investment portfolio of Occudo Quantitative Strategies LP, based on Form 13F filings with the SEC.

Stay updated on Occudo Quantitative Strategies LP with notifications on news.